Both in Pharmaceuticals
Xilio Therapeutics vs Nomad Power Solutions
Over the past year XLO returned −19.1% and NMAD returned +7.8%; their daily moves had a correlation of 0.18.
XLO −19.1% NMAD +7.8%Growth of $1, one year, split-adjusted
| Metric | XLO | NMAD |
|---|---|---|
| Price | $7.22 | $3.82 |
| Market cap | $47.5M | $61.4M |
| Today | −4.56% | +0.13% |
| 1 month | −20.1% | +6.6% |
| 6 months | −11.7% | — |
| Year to date | −19.4% | — |
| 1 year | −33.3% | — |
| Revenue growth (YoY) | +131.2% | — |
| Gross margin | 100.0% | — |
| Net margin | −34.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.7× | — |
| Net cash | $136.0M | — |
| Dividend yield | — | — |
| Volatility (60d) | 27.7% | — |
| Short % of float | 10.3% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).